Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupus Erythematosus, Systemic
|
1172 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.900 | 0.867 | 15 | 2008 | 2019 | |||||
Rheumatoid Arthritis
|
2387 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.080 | 1.000 | 8 | 2010 | 2017 | |||||
Arthritis
|
69 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Psoriasis
|
705 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||
Sjogren's Syndrome
|
47 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.020 | 1.000 | 2 | 2011 | 2018 | |||||
Crohn Disease
|
1147 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Adult Lymphoma
|
66 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Childhood Lymphoma
|
66 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Lymphoma
|
91 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Primary Sjögren's syndrome
|
42 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||
Adult type dermatomyositis
|
31 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Dermatomyositis
|
34 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Lung Diseases, Interstitial
|
144 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Polymyositis
|
22 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
23 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Hepatitis B
|
519 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1 | 2015 | 2015 | ||||||
Hepatitis B, Chronic
|
84 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Hepatitis, Chronic
|
10 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1 | 2015 | 2015 | ||||||
Liver carcinoma
|
942 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1 | 2015 | 2015 | ||||||
Immune thrombocytopenic purpura
|
35 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Collagen Diseases
|
10 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Rheumatism
|
19 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Systemic Scleroderma
|
287 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||
B-Cell Lymphomas
|
42 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Lymphoma, Large-Cell, Follicular
|
6 | 0.662 | 0.440 | 6 | 137874929 | missense variant | T/C;G | snv | 4.0E-06; 5.4E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 |